Literature DB >> 15512802

Secretion of ferritin by iron-laden macrophages and influence of lipoproteins.

Xi-Ming Yuan1, Wei Li, Sarah K Baird, Maria Carlsson, Ojar Melefors.   

Abstract

Increasing evidence supports a role of cellular iron in the initiation and development of atherosclerosis. We and others reported earlier that iron-laden macrophages are associated with LDL oxidation, angiogenesis, nitric oxide production and apoptosis in atherosclerotic processes. Here we have further studied perturbed iron metabolism in macrophages, their interaction with lipoproteins and the origin of iron accumulation in human atheroma. In both early and advanced human atheroma lesions, hemoglobin and ferritin accumulation correlated with the macrophage-rich areas. Iron uptake into macrophages, via transferrin receptors or scavenger receptor-mediated erythrophagocytosis, increased cellular iron and accelerated ferritin synthesis at both mRNA and protein levels. The binding activity of iron regulatory proteins was enhanced by desferrioxamine (DFO) and decreased by hemin and iron compounds. Iron-laden macrophages exocytosed both iron and ferritin into the culture medium. Exposure to oxidized low-density lipoprotein (oxLDL, >or=50 microg/mL) resulted in <20% apoptosis of iron-laden human macrophages, but cells remained impermeable after a 24 h period and an increased excretion of ferritin could be observed by immunostaining techniques. Exposure to high-density lipoprotein (HDL) significantly decreased ferritin excretion from these cells. We conclude: (i) erythrophagocytosis and hemoglobin catabolism by macrophages contribute to ferritin accumulation in human atherosclerotic lesions and; (ii) iron uptake into macrophages leads to increased synthesis and secretion of ferritin; (iii) oxidized LDL and HDL have different effects on these processes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15512802     DOI: 10.1080/10715760400011692

Source DB:  PubMed          Journal:  Free Radic Res        ISSN: 1029-2470


  18 in total

1.  In vivo phage display selection yields atherosclerotic plaque targeted peptides for imaging.

Authors:  Kimberly A Kelly; Matthias Nahrendorf; Amy M Yu; Fred Reynolds; Ralph Weissleder
Journal:  Mol Imaging Biol       Date:  2006 Jul-Aug       Impact factor: 3.488

Review 2.  Hepcidin and HFE protein: Iron metabolism as a target for the anemia of chronic kidney disease.

Authors:  Elena Canavesi; Carlo Alfieri; Serena Pelusi; Luca Valenti
Journal:  World J Nephrol       Date:  2012-12-06

Review 3.  A possible role for secreted ferritin in tissue iron distribution.

Authors:  Esther G Meyron-Holtz; Shirly Moshe-Belizowski; Lyora A Cohen
Journal:  J Neural Transm (Vienna)       Date:  2011-02-06       Impact factor: 3.575

4.  Haemin-enhanced expression of haem oxygenase-1 stabilizes erythrocyte-induced vulnerable atherosclerotic plaques.

Authors:  Hui Li Lin; Lei Zhang; Chun Xi Liu; Xin Sheng Xu; Meng Xiong Tang; Hui Xia Lv; Chang Jiang Li; Hui Wen Sun; Mei Zhang; Jiang Hong; Yun Zhang
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

5.  Microcytic anemia, erythropoietic protoporphyria, and neurodegeneration in mice with targeted deletion of iron-regulatory protein 2.

Authors:  Sharon S Cooperman; Esther G Meyron-Holtz; Hayden Olivierre-Wilson; Manik C Ghosh; Joseph P McConnell; Tracey A Rouault
Journal:  Blood       Date:  2005-04-14       Impact factor: 22.113

6.  Systemic iron chelation results in limited functional and histological recovery after traumatic spinal cord injury in rats.

Authors:  Andrew Sauerbeck; David L Schonberg; James L Laws; Dana M McTigue
Journal:  Exp Neurol       Date:  2013-05-24       Impact factor: 5.330

7.  In vivo role(s) of the iron regulatory proteins (IRP) 1 and 2 in aseptic local inflammation.

Authors:  Lydie Viatte; Hermann-Josef Gröne; Matthias W Hentze; Bruno Galy
Journal:  J Mol Med (Berl)       Date:  2009-06-17       Impact factor: 4.599

8.  A proteomic approach to differentiate histologically classified stable and unstable plaques from human carotid arteries.

Authors:  Antonio J Lepedda; Antonio Cigliano; Gian Mario Cherchi; Rita Spirito; Marco Maggioni; Franco Carta; Franco Turrini; Celina Edelstein; Angelo M Scanu; Marilena Formato
Journal:  Atherosclerosis       Date:  2008-07-12       Impact factor: 5.162

9.  Scara5 is a ferritin receptor mediating non-transferrin iron delivery.

Authors:  Jau Yi Li; Neal Paragas; Renee M Ned; Andong Qiu; Melanie Viltard; Thomas Leete; Ian R Drexler; Xia Chen; Simone Sanna-Cherchi; Farah Mohammed; David Williams; Chyuan Sheng Lin; Kai M Schmidt-Ott; Nancy C Andrews; Jonathan Barasch
Journal:  Dev Cell       Date:  2009-01       Impact factor: 12.270

Review 10.  Hyperferritinaemia-cataract syndrome: worldwide mutations and phenotype of an increasingly diagnosed genetic disorder.

Authors:  Gunda Millonig; Martina U Muckenthaler; Sebastian Mueller
Journal:  Hum Genomics       Date:  2010-04       Impact factor: 4.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.